Literature DB >> 8554950

Quality of life and care in Parkinson's disease.

C E Clarke1, R M Zobkiw, E Gullaksen.   

Abstract

Seventy-two parkinsonian patients attending a subregional movement disorder clinic completed a novel questionnaire designed to examine their quality of life and care. Significant problems with housing, travel, holidays and hobbies were identified. Financial difficulties due to premature retirement and the complex benefit system were found. Many carers were ill but, even when hospitalised, patients were cared for in the community by friends and relatives. Few patients had been referred for paramedical therapies, in spite of considerable disability in some cases. Aids and adaptations were commonly in use without advice from an occupational therapist. The specialised clinic and Parkinson's disease nurse advisor were welcomed by many patients. Most were satisfied with their hospital care and general practitioner, but follow-up arrangements with general practitioners were variable. It is suggested that further research concentrates on the roles of physiotherapy, speech therapy, nurse advisors and social workers in the management of Parkinson's disease, and on the value of increased carer support, including respite care.

Entities:  

Mesh:

Year:  1995        PMID: 8554950

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN: 0007-0947


  19 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease.

Authors:  Vladana Spica; Tatjana Pekmezović; Marina Svetel; Vladimir S Kostić
Journal:  J Neurol       Date:  2012-07-22       Impact factor: 4.849

3.  Quality of life of caregivers.

Authors:  Janna M Glozman
Journal:  Neuropsychol Rev       Date:  2004-12       Impact factor: 7.444

4.  Cost of illness and its predictors for Parkinson's disease in Germany.

Authors:  Annika E Spottke; Martin Reuter; Olaf Machat; Bernhard Bornschein; Sonja von Campenhausen; Karin Berger; Rudolf Koehne-Volland; Jürgen Rieke; Alexander Simonow; Dirk Brandstaedter; Uwe Siebert; Wolfgang H Oertel; Gudrun Ulm; Richard Dodel
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 5.  Health-related quality-of-life measurement in patients with Parkinson's disease.

Authors:  C Jenkinson; R Fitzpatrick; V Peto
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

6.  Quality of life and gender identity in Parkinson's disease.

Authors:  O Moore; S Kreitler; M Ehrenfeld; N Giladi
Journal:  J Neural Transm (Vienna)       Date:  2005-03-23       Impact factor: 3.575

Review 7.  Economic and health-related quality of life considerations of new therapies in Parkinson's disease.

Authors:  L M Rubenstein; A DeLeo; E A Chrischilles
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

8.  Being a Parkinson's patient: immobile and unpredictably whimsical literature and existential analysis.

Authors:  Harry Van Der Bruggen; Guy Widdershoven
Journal:  Med Health Care Philos       Date:  2004

9.  Loss of ability to work and ability to live independently in Parkinson's disease.

Authors:  Barbara Jasinska-Myga; Michael G Heckman; Christian Wider; John D Putzke; Zbigniew K Wszolek; Ryan J Uitti
Journal:  Parkinsonism Relat Disord       Date:  2011-10-04       Impact factor: 4.891

10.  Cost effectiveness of treatment of Parkinson's disease with entacapone in the United States.

Authors:  Cynthia S Palmer; Mark J C Nuijten; Jordana K Schmier; Prasun Subedi; Edward H Snyder
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.